JAK2 and osteosarcoma: Ge et al. also demonstrated that through the JAK2/STAT3 pathway, BMSC derived exosomal lymphocyte cytosolic protein 1 (LCP1) could promote osteosarcoma proliferation and metastasis (Ge et al., 2020).